Stem Cells Spin Balance Sheet Health
Financial Health criteria checks 5/6
Stem Cells Spin has a total shareholder equity of PLN7.4M and total debt of PLN115.6K, which brings its debt-to-equity ratio to 1.6%. Its total assets and total liabilities are PLN13.7M and PLN6.3M respectively.
Key information
1.6%
Debt to equity ratio
zł115.62k
Debt
Interest coverage ratio | n/a |
Cash | zł6.60k |
Equity | zł7.43m |
Total liabilities | zł6.28m |
Total assets | zł13.71m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SCS's short term assets (PLN776.1K) exceed its short term liabilities (PLN172.2K).
Long Term Liabilities: SCS's short term assets (PLN776.1K) do not cover its long term liabilities (PLN6.1M).
Debt to Equity History and Analysis
Debt Level: SCS's net debt to equity ratio (1.5%) is considered satisfactory.
Reducing Debt: SCS's debt to equity ratio has reduced from 12.8% to 1.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable SCS has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: SCS is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 20.4% per year.